Inductive Bio Job Trends

Inductive Bio logo
1
Active Jobs (Last 14 Days)
1
Fresh Jobs (Last 3 Days)
100%
Jobs with Salary Data

Recent Job Posting Activity (30 Days)

Inductive Bio 30-day hiring trend

Job Category Distribution

Inductive Bio job category distribution
Data spans Sep 18, 2026 through Oct 18, 2026, aggregated by PharmaPayWatch.com. Recent job postings shows the number of jobs posted each day (bars) for the past 30 days with an overlay of the 7 day running average. The rose plot shows how PharmaPayWatch categorizes those jobs to get a better sense of Inductive Bio's recent hiring focus. Note that some jobs aren't categorized by our filters, we exclude those from the rose plot.

Current Inductive Bio Jobs, Salary Data, and Stats

In the last two weeks, Inductive Bio has posted 1 positions. None of those roles offer remote or hybrid work. We've been tracking Inductive Bio since May 21, 2025.

Career Tracks Currently Hiring

Other Software & IT Commercial Scientific Research Data Science

Currently Hiring Office Locations

New York City, San Francisco, or Boston New York City Woburn, MA Boston, MA

Current Inductive Bio Jobs

Last updated: Oct 17, 2026

Showing 1 active jobs. Active jobs were posted in the last 14 days. Fresh jobs were posted within the last 3 days. Click a row for more details.

Role

Synthetic Chemist

Fresh Research Oct 16
$210,000 - $250,000
Boston, MA
Apply →
Inductive Bio is an AI medicinal chemistry partner. We build virtual labs that help drug discovery teams make better decisions, faster, across the full Design-Make-Test-Analyze (DMTA) cycle. Our platform includes Beacon-2 ADMET prediction models, human dose projection tools, and Indy, an AI medicinal chemistry assistant. Through partnerships with CROs, we also offer innovative synthesis approaches, direct-to-dose testing, and cost-effective Tier 1 ADME panels that enable initial human PK projection, closing the loop from computational design to experimental validation. Together, these capabilities power dozens of small molecule and beyond-rule-of-five programs for biotech and pharma partners. We've raised $30M from Obvious Ventures,...